Hubei Minkang Pharmaceutical Ltd (OTCBB:HBMK) signed a memorandum of understanding to acquire 51% stake in Henan Wanlong Pharmaceutical Co., Ltd. on February 29, 2012. As of December 31, 2011, current turnover of Henan Wanlong is estimated at CNY 700 million to CNY 800 million.

Hubei Minkang Pharmaceutical Ltd (OTCBB:HBMK) cancelled the acquisition of 51% stake in Henan Wanlong Pharmaceutical Co., Ltd. on June 28, 2013.